Sort
17,054 grants matching “genome editing”
Integrative Technologies Support Core
$266,274Ying Xia · University Of Cincinnati · P30 · FY2020 · ES
Integrative Technologies Support Core
$266,274Ying Xia · University Of Cincinnati · P30 · FY2022 · ES
Identification of potent small molecule inhibitors of Cas9
$266,250Amit Choudhary · Brigham And Women'S Hospital · R21 · FY2016 · AI
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
$266,250James Even Voss · Scripps Research Institute, The · R21 · FY2020 · AI
3/3 Multidimensional investigation of the etiology of autism spectrum disorder
$266,208Nenad Sestan · Yale University · R01 · FY2016 · MH
Preclinical Models Core (Core A)
$266,204Guillermo C Oliver · Northwestern University At Chicago · P30 · FY2020 · DK
Preclinical Models Core (Core A)
$266,203Guillermo C Oliver · Northwestern University At Chicago · P30 · FY2018 · DK
Preclinical Models Core (Core A)
$266,203Guillermo C Oliver · Northwestern University At Chicago · P30 · FY2019 · DK
Preclinical Models Core (Core A)
$266,203Guillermo C Oliver · Northwestern University At Chicago · P30 · FY2021 · DK
Preclinical Models Core (Core A)
$266,203Guillermo C Oliver · Northwestern University At Chicago · P30 · FY2022 · DK
Integrative Technologies Support Core
$266,067Yuet-Kin Leung · University Of Cincinnati · P30 · FY2019 · ES
Genetic Engineering Technologies Shared Resource
$266,005Cathleen M Lutz · Jackson Laboratory · P30 · FY2024 · CA
Mechanisms controlling tissue morphogenesis, architecture, and the response to mechanical forces in C. elegans.
$265,987David S Fay · University Of Wyoming · R01 · FY2017 · GM
Cell biology of autosomal dominant polycystic kidney disease
$265,500Jing Zhou · Brigham And Women'S Hospital · R01 · FY2015 · DK
Rapid Development of Mouse Resource Strains through the Application of Prime Editors
$265,500David E Bergstrom · Jackson Laboratory · R21 · FY2024 · OD
Safe, CRISPR/Cas-free B cell editing for therapeutic applications
$265,500Michael R. Farzan · Boston Children'S Hospital · R21 · FY2024 · AI
Recombinase polymerase amplification to enable same-cell, DNA/RNA multi-omic single cell sequencing
$265,500Daniel Higginson · Sloan-Kettering Inst Can Research · R21 · FY2024 · GM
Cell biology of autosomal dominant polycystic kidney disease
$265,500Jing Zhou · Brigham And Women'S Hospital · R01 · FY2016 · DK
Characterization of nuclear retained RNA-mediated gene regulatory mechanism
$265,393Prasanth Kumar Vijayan Kannanganattu · University Of Illinois At Urbana-Champaign · R01 · FY2012 · GM
Characterization of nuclear retained RNA-mediated gene regulatory mechanism
$265,393Prasanth Kumar Vijayan Kannanganattu · University Of Illinois At Urbana-Champaign · R01 · FY2014 · GM
Characterization of nuclear retained RNA-mediated gene regulatory mechanism
$265,393Prasanth Kumar Vijayan Kannanganattu · University Of Illinois At Urbana-Champaign · R01 · FY2015 · GM
Characterization of nuclear retained RNA-mediated gene regulatory mechanism
$265,393Prasanth Kumar Vijayan Kannanganattu · University Of Illinois At Urbana-Champaign · R01 · FY2011 · GM
Development of POC system for patient condition and treatment monitoring in Sickle Cell Disease through hypoxia-induced sickling
$265,347Patrick Hines · Functional Fluidics, Llc · R43 · FY2024 · HL
Core 2
$265,257Jennifer A Doudna · University Of California, San Francisco · U54 · FY2024 · AI
Integrative Technologies Support Core
$265,237Yuet-Kin Leung · University Of Cincinnati · P30 · FY2018 · ES